Related Experiment Video
Updated: Mar 25, 2026

Imaging and Quantifying Mitochondrial Morphology in C. elegans During Aging
Published on: January 17, 2025
C. elegans as a model organism for human mitochondrial associated disorders
Silvia Maglioni1, Natascia Ventura2
1IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany.
Mitochondrial dysfunction causes severe genetic disorders. The nematode C. elegans offers a powerful model for studying these diseases and screening for new therapies to improve mitochondrial health.
Area of Science:
- Cell Biology
- Genetics
- Neuroscience
Background:
- Mitochondria are vital for cellular energy production.
- Cells have quality control mechanisms for mitochondrial homeostasis.
- Severe mitochondrial damage leads to genetic disorders and diseases.
Purpose of the Study:
- To summarize the utility of Caenorhabditis elegans as a model organism for neurodegenerative diseases.
- To investigate mitochondrial electron transport chain defects.
- To screen for potential therapeutic interventions.
Main Methods:
- Utilizing the nematode C. elegans model system.
- Analyzing genetic disorders linked to mitochondrial defects.
- Screening for therapeutic compounds.
Main Results:
- C. elegans provides insights into mitochondrial disease pathogenesis.
- The nematode system aids in identifying therapeutic targets.
- Conserved genetic pathways are revealed.
Conclusions:
- C. elegans is advantageous for modeling mitochondrial neurodegenerative diseases.
- This model facilitates the discovery of novel therapeutic strategies.
- Further research in C. elegans can advance treatments for mitochondrial disorders.
More Related Videos
05:51Comparative Analysis of Experimental Methods to Quantify Animal Activity in Caenorhabditis elegans Models of Mitochondrial Disease
Published on: April 4, 2021
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025